Research location
Mbeya
Tanzania
Advertisement
Research activity in Mbeya
TanzaniaCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 34 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mbeya
34 linked trials · page 1 of 1Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TBNCT06568484 · 2026-05-08 · 1 site observation
RECRUITING
10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected AdultsNCT05890963 · 2023-11-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered ServiceNCT05342064 · 2023-07-11 · 1 site observation
ACTIVE_NOT_RECRUITING
SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian YouthNCT05374109 · 2023-03-01 · 1 site observation
COMPLETED
TB-CAPT EXULTANT - HIVNCT04568967 · 2022-09-05 · 1 site observation
COMPLETED
Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes MellitusNCT04600167 · 2022-06-17 · 1 site observation
UNKNOWN
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)NCT04032522 · 2019-10-23 · 1 site observation
COMPLETED
Family Psychoeducation for Adults With Psychotic Disorders in TanzaniaNCT04013932 · 2019-08-06 · 1 site observation
COMPLETED
Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceNCT03512249 · 2019-01-31 · 1 site observation
COMPLETED
Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult ParticipantsNCT03122223 · 2018-01-16 · 1 site observation
COMPLETED
Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.NCT03334552 · 2017-10-15 · 1 site observation
UNKNOWN
Safety and Immune Response to a Clade C DNA HIV VaccineNCT02997969 · 2016-06-21 · 1 site observation
COMPLETED
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in WomenNCT02568215 · 2016-05-01 · 1 site observation
COMPLETED
Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV InfectionNCT02591420 · 2016-04-01 · 1 site observation
COMPLETED
HIV Point-of-Care Test Evaluation in InfantsNCT02545296 · 2015-07-01 · 1 site observation
COMPLETED
A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected PatientsNCT01770730 · 2013-01-01 · 1 site observation
COMPLETED
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy RegimenNCT01714414 · 2012-12-01 · 1 site observation
COMPLETED
A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and MozambiqueNCT01697007 · 2012-11-01 · 1 site observation
COMPLETED
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/RitonavirNCT01255371 · 2012-03-01 · 1 site observation
WITHDRAWN
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected AdultsNCT01260727 · 2010-02-01 · 1 site observation
COMPLETED
Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African AdultsNCT00123968 · 2006-05-01 · 1 site observation
COMPLETED
A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the PastNCT00001029 · 1 site observation
COMPLETED
Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia ProphylaxisNCT00000816 · 1 site observation
COMPLETED
A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or SulfonamidesNCT00000802 · 1 site observation
COMPLETED
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI MonotherapyNCT00000831 · 1 site observation
COMPLETED
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected PatientsNCT00000991 · 1 site observation
COMPLETED
A Study of Disease Progression and Anti-HIV TreatmentsNCT00001068 · 1 site observation
COMPLETED
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical TumorsNCT00001073 · 1 site observation
COMPLETED
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3NCT00000625 · 1 site observation
COMPLETED
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)NCT00000676 · 1 site observation
COMPLETED
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleNCT00001065 · 1 site observation
COMPLETED
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsNCT00001030 · 1 site observation
COMPLETED
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDSNCT00001058 · 1 site observation
COMPLETED
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV InfectionNCT00000793 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.